July 13, 2017 / 8:43 AM / 11 days ago

Gerresheimer says has solid orders for H2 in U.S. glass

1 Min Read

FRANKFURT, July 13 (Reuters) - Gerresheimer already has firm orders for 80 percent of what it expects to make in second-half sales in its U.S. glass business, Chief Executive Uwe Roehrhoff told reporters on Thursday, reiterating his optimism about the end of the year.

The German drugs-packaging firm earlier reported lower second-quarter sales and earnings, partly due to U.S. customer uncertainty over healthcare policy, but said it expected a rebound in the fourth quarter.

Roehrhoff also said he expected shortly to be able to fill a gap in Gerresheimer's portfolio by acquiring syringe-security technology that would protect needles, which is a regulatory requirement in many regions. (Reporting by Georgina Prodhan; Editing by Maria Sheahan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below